Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W. Koek

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Annals of the New York Academy of Sciences|November 25, 1997
Poly(ADP-ribose) polymerase (PARP) revisited. A new role for an old enzyme: PARP involvement in neurodegeneration and PARP inhibitors as possible neuroprotective agentsC Cosi, H Suzuki, S D Skaper, et al.
Neuropharmacology|November 9, 2002
Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesiaF C Colpaert, J P Tarayre, W Koek, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 1998
F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potentialW Koek, J F Patoiseau, M B Assié, et al.
Molecular Psychiatry|June 12, 2023
Ethanol inhibits dopamine uptake via organic cation transporter 3: Implications for ethanol and cocaine co-abuseN J Clauss, F P Mayer, W A Owens, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraineG W John, P J Pauwels, M Perez, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Annals of the New York Academy of Sciences|November 25, 1997
Poly(ADP-ribose) polymerase (PARP) revisited. A new role for an old enzyme: PARP involvement in neurodegeneration and PARP inhibitors as possible neuroprotective agentsC Cosi, H Suzuki, S D Skaper, et al.
Neuropharmacology|November 9, 2002
Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesiaF C Colpaert, J P Tarayre, W Koek, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 1998
F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potentialW Koek, J F Patoiseau, M B Assié, et al.
Molecular Psychiatry|June 12, 2023
Ethanol inhibits dopamine uptake via organic cation transporter 3: Implications for ethanol and cocaine co-abuseN J Clauss, F P Mayer, W A Owens, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraineG W John, P J Pauwels, M Perez, et al.
Pageof 10